$-0.04
(Market cap
$40 Mln
Revenue (TTM)
$11 Mln
P/E Ratio
--
P/B Ratio
1.3
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-2 %
-
ROCE
-- %
-
Industry P/E
44.46
-
EV/EBITDA
0.5
-
Debt to Equity
0
-
Book Value
$0.7
-
EPS
$-0.5
-
Face value
--
-
Shares outstanding
46,838,962
10 Years Aggregate
CFO
$-118.21 Mln
EBITDA
$-132.55 Mln
Net Profit
$-138.73 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
InspireMD (NSPR)
| -52.2 | 23.3 | -3.4 | -65.2 | -35.9 | -28.5 | -68.4 |
|
BSE Sensex*
| -9.1 | -1.2 | 2.9 | -3.6 | 5.7 | 6.2 | 10.5 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
InspireMD (NSPR)
| -32.3 | -6.4 | 226.9 | -71.5 | -40.8 | -68.5 | -86.5 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
InspireMD (NSPR)
|
0.9 | 39.8 | 10.8 | -38.5 | -354.6 | -88.8 | -- | 1.3 |
| 61.5 | 8,018.1 | 616.9 | -75.1 | 1.7 | -9.3 | -- | 10.2 | |
| 14.6 | 9,638.1 | 6,561.1 | -578.0 | -4.5 | -10.3 | -- | 1.7 | |
| 365.1 | 9,761.6 | 2,589.3 | 222.4 | -6.0 | 3 | 44.5 | 1.3 | |
| 57.1 | 8,696.7 | 3,499.6 | -71.2 | 0.5 | -3.2 | -- | 3.8 | |
| 179.9 | 10,905.5 | 612.8 | -188.1 | -30.6 | -28.1 | -- | 16.4 | |
| 100.8 | 6,577.5 | 1,556.3 | 275.3 | 24.6 | 22.9 | 24.1 | 5.0 | |
| 90.5 | 5,403.2 | 1,579.2 | 145.6 | 14.3 | 8.9 | 37.2 | 3.2 | |
| 321.7 | 12,752.7 | 1,504.9 | 160.6 | 13.6 | 10.9 | 79.4 | 8.4 | |
| 176.3 | 9,947.9 | 785.1 | 41.5 | 9.9 | 2 | 251.8 | 4.9 |
Shareholding Pattern
View DetailsAbout InspireMD (NSPR)
InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery disease and other vascular conditions in the United States, Germany, Italy, Russia, Poland, and... internationally. It offers MicroNet, a biocompatible polymer mesh material for medical implants, as well as for treating plaque prolapse and embolization; CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Carotid Stent System; and SwitchGuard neuroprotection system to provide flow reversal of cerebral protection in carotid interventions, as well as treating acute stroke with tandem lesions. The company was founded in 2005 and is headquartered in Miami, Florida. Read more
-
President, CEO & Director
Mr. Marvin L. Slosman
-
President, CEO & Director
Mr. Marvin L. Slosman
-
Headquarters
Miami, FL
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for InspireMD (NSPR)
What is the current share price of InspireMD Inc (NSPR) Today?
The share price of InspireMD Inc (NSPR) is $0.85 (NASDAQ) as of 28-Aug-2026 16:00 EDT. InspireMD Inc (NSPR) has given a return of -35.92% in the last 3 years.
What is the current PB & PE ratio of InspireMD Inc (NSPR)?
Since, TTM earnings of InspireMD Inc (NSPR) is negative, P/E ratio is not available.
The P/B ratio of InspireMD Inc (NSPR) is 1.32 times as on 28-Aug-2026, a 65 discount to its peers’ median range of 3.79 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-2.68 |
2.37 |
2024 |
-4.02 |
3.56 |
2023 |
-3.42 |
1.73 |
2022 |
-0.37 |
0.40 |
2021 |
-1.58 |
0.70 |
What is the 52 Week High and Low of InspireMD Inc (NSPR)?
The 52-week high and low of InspireMD Inc (NSPR) are Rs 2.57 and Rs 0.63 as of 31-Aug-2026.
What is the market cap of InspireMD Inc (NSPR)?
InspireMD Inc (NSPR) has a market capitalisation of $ 40 Mln as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in InspireMD Inc (NSPR)?
Before investing in InspireMD Inc (NSPR), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.